相关实验视频

Updated: Jun 24, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

用于癌症免疫治疗的工程T细胞受体

So Won Lee¹, Hyang-Mi Lee¹

¹College of Pharmacy, Dongduk Women's University, Seoul 02748, Republic of Korea.

Biomolecules & therapeutics

|June 6, 2024

概括

工程T细胞疗法,包括T细胞受体 (TCR) -T细胞,显示出治疗固体瘤的希望. 本综述侧重于TCR-T细胞疗法,探讨其特征和超出血液癌症的临床应用.

科学领域:

免疫学和瘤学
细胞疗法细胞疗法
生物技术是生物技术.

背景情况:

癌症免疫疗法包括各种策略,如免疫调节抗体,癌症疫苗和采用T细胞转移.
由于其瘤细胞细胞毒性和特定受体结合,T细胞至关重要.
基因工程T细胞,如仿真抗原受体-T细胞 (CAR-T) 和T细胞受体 (TCR) -T细胞,增强治疗特异性和疗效.

研究的目的:

审查抗瘤T细胞疗法,特别关注工程T细胞受体 (TCR) -T细胞疗法.
概述TCR-T细胞治疗的特征.
讨论TCR-T细胞治疗在非血液性恶性瘤的临床应用.

主要方法:

对基于T细胞的癌症免疫疗法现有文献的综述.
分析工程T细胞疗法的机制和特性,特别是TCR-T细胞.
检查临床数据和TCR-T细胞治疗在固体瘤中的应用.

主要成果:

采用CAR-T细胞的细胞转移已经在治疗血液性恶性瘤方面取得了成功.
TCR-T细胞疗法涉及对T细胞进行基因改造,以表达针对瘤相关抗原的特定TCRs.
这种方法旨在将T细胞治疗的好处扩展到固体瘤.

结论:

工程TCR-T细胞疗法代表了扩展T细胞疗法到固体瘤的有希望的策略.
了解TCR-T细胞的特征和临床应用对于推进它们在非血液性恶性瘤中的应用至关重要.
TCR-T细胞疗法为向固体瘤提供了增强的特异性和有效性.

关键词:

在CAR-T细胞中.癌症免疫疗法癌症免疫疗法固体瘤是一个固体瘤.在TCR-T细胞中.

更多相关视频

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...